Literature DB >> 21222066

Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors.

Luciana Regina Moreira1, André Almeida Schenka, Paulo Latuf-Filho, André Lisboa Penná, Carmen S P Lima, Fernando Augusto Soares, Miriam Aparecida Silva Trevisan, José Vassallo.   

Abstract

Analysis of blood and lymphatic vessel in colorectal cancer is controversial in the literature, possibly due to variations in the methods of analysis. In this study, it was aimed to search for a reliable approach in the quantification of angio- and lymphangiovascular density and area as a prognostic factor and to compare such vessel counts in normal mucosa, adenomas and cancer. A retrospective study was performed on 60 sporadic colorectal cancer, 30 colorectal adenomas, and 10 colorectal non-neoplastic lesions. Archival tissues were submitted to immunohistochemical evaluation using antibodies to CD31, CD34, CD105, VEGF-A, VEGF-C, and D2-40. Microvessel density and total vascular area were determined by computer image analysis and values were compared in the three groups of lesions; the prognostic value of these parameters was evaluated in the group of colorectal cancer. Most markers showed progressive vessel counts from non-neoplastic tissue to carcinoma, both for microvessel density and total vascular area. Only microvessel density determined by CD34 in the central areas of the cancer correlated with recurrence/metastasis (p = 0.04) and survival (p = 0.02). Different methods of quantification (microvessel counting versus estimation of total vascular area), immunohistochemical markers (pan-endothelial marker versus neovessels and lymphatic markers), and areas of analysis (periphery versus inner portions of the lesion) were assessed using image analysis. The results corroborate the increase in vascularization of carcinoma and suggest that microvessel density determined by immunostaining for CD34 in the inner portion of the tumor might represent a prognostically relevant parameter in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21222066     DOI: 10.1007/s13277-010-0147-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  37 in total

1.  Should Dukes' B patients receive adjuvant therapy? A statistical perspective.

Authors:  M Buyse; P Piedbois
Journal:  Semin Oncol       Date:  2001-02       Impact factor: 4.929

Review 2.  Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours.

Authors:  P B Vermeulen; G Gasparini; S B Fox; C Colpaert; L P Marson; M Gion; J A M Beliën; R M W de Waal; E Van Marck; E Magnani; N Weidner; A L Harris; L Y Dirix
Journal:  Eur J Cancer       Date:  2002-08       Impact factor: 9.162

3.  'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer.

Authors:  A Giatromanolaki; M I Koukourakis; E Sivridis; K O'Byrne; K C Gatter; A L Harris
Journal:  J Pathol       Date:  2000-10       Impact factor: 7.996

Review 4.  Epidemiology, disease progression, and economic burden of colorectal cancer.

Authors:  Al B Benson
Journal:  J Manag Care Pharm       Date:  2007-08

Review 5.  Biology of angiogenesis in tumors of the gastrointestinal tract.

Authors:  Niels Reinmuth; Alexander A Parikh; Syed A Ahmad; Wenbiao Liu; Oliver Stoeltzing; Fan Fan; Akihiko Takeda; Morihisa Akagi; Lee M Ellis
Journal:  Microsc Res Tech       Date:  2003-02-01       Impact factor: 2.769

6.  A morphometric study of neovascularization in colorectal carcinoma.

Authors:  P M Pavlopoulos; A E Konstantinidou; E Agapitos; N Kavantzas; P Nikolopoulou; P Davaris
Journal:  Cancer       Date:  1998-11-15       Impact factor: 6.860

7.  Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer.

Authors:  J Gao; A Knutsen; G Arbman; J Carstensen; B Frånlund; X F Sun
Journal:  Dig Liver Dis       Date:  2008-11-26       Impact factor: 4.088

8.  Correlative study of microvessel density and 5-lipoxygenase expression in human sporadic colorectal cancer.

Authors:  Valeria Barresi; Enrica Vitarelli; Giovanni Tuccari; Gaetano Barresi
Journal:  Arch Pathol Lab Med       Date:  2008-11       Impact factor: 5.534

9.  Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer.

Authors:  S E Duff; M Jeziorska; S Kumar; N Haboubi; D Sherlock; S T O'Dwyer; G C Jayson
Journal:  Colorectal Dis       Date:  2007-11       Impact factor: 3.788

10.  Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma.

Authors:  Shu Zheng; Ming-Yong Han; Zuo-Xiang Xiao; Jia-Ping Peng; Qi Dong
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

View more
  9 in total

1.  Long-Term Outcomes of Endoscopic Versus Surgical Resection of Superficial Submucosal Colorectal Cancer.

Authors:  Ji-Beom Kim; Ho Su Lee; Hyo Jeong Lee; Jihun Kim; Dong-Hoon Yang; Chang Sik Yu; Jin Cheon Kim; Jeong-Sik Byeon
Journal:  Dig Dis Sci       Date:  2015-01-14       Impact factor: 3.199

2.  Immunohistochemical expression of PCNA and CD34 in colorectal adenomas and carcinomas using specified automated cellular image analysis system: a clinicopathologic study.

Authors:  Ban J Qasim; Hussam H Ali; Alaa G Hussein
Journal:  Saudi J Gastroenterol       Date:  2012 Jul-Aug       Impact factor: 2.485

Review 3.  Can vascular endothelial growth factor and microvessel density be used as prognostic biomarkers for colorectal cancer? A systematic review and meta-analysis.

Authors:  Yibaina Wang; Xiaoping Yao; Jie Ge; Fulan Hu; Yashuang Zhao
Journal:  ScientificWorldJournal       Date:  2014-03-27

Review 4.  Lymphangiogenesis and colorectal cancer.

Authors:  Ciyou Huang; Yigang Chen
Journal:  Saudi Med J       Date:  2017-03       Impact factor: 1.484

Review 5.  Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review.

Authors:  Daniel Sur; Andrei Havasi; Cristian Virgil Lungulescu; Simona Ruxandra Volovat; Claudia Burz; Alexandru Irimie
Journal:  Med Pharm Rep       Date:  2022-07-26

6.  PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts.

Authors:  Sophie J Deharvengt; Dan Tse; Olga Sideleva; Caitlin McGarry; Jason R Gunn; Daniel S Longnecker; Catherine Carriere; Radu V Stan
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

7.  The clinical implication of cancer-associated microvasculature and fibroblast in advanced colorectal cancer patients with synchronous or metachronous metastases.

Authors:  Yoonjin Kwak; Hee Eun Lee; Woo Ho Kim; Duck-Woo Kim; Sung-Bum Kang; Hye Seung Lee
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

8.  VEGF-C expression is not a prognostic factor in locally advanced colon adenocarcinoma.

Authors:  Mariusz Szajewski; Wiesław Janusz Kruszewski; Joanna Lakomy; Maciej Ciesielski; Krzysztof Kawecki; Jarosław Szefel
Journal:  Contemp Oncol (Pozn)       Date:  2016-01-13

9.  Correlations Between Intratumoral Microvessel Density and Histopathological Type or Neoadjuvant Radiotherapy for Rectal Carcinoma.

Authors:  T Dumitrescu; C D Uscatu; D O Alexandru; S Ş Meşină; I Dincă; E Moraru; A Dumitrescu; D I Gheonea; R E Nicoli; I Vasile
Journal:  Curr Health Sci J       Date:  2015-04-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.